Skip to main content
Line Stensig Lynggaard on Muck Rack

Line Stensig Lynggaard

As seen in: Nature, Wiley Online Library, Physician's Weekly
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Line Stensig

Contact Line Stensig, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Severe toxicity-free survival following acute lymphoblastic leukemia in patients aged 1–45 years: a Danish cohort study - Leukemia

|
By Bodil Als-Nielsen, Birgitte Klug Albertsen, Andreja Dimitrijevic, Henrik Hjalgrim, Marianne Ifversen, Line Stensig Lynggaard, Marianne Olsen, Ulrik Malthe Overgaard, Cecilie Utke Rank, Mathias Rathe, Klaus Rostgaard, Kjeld Schmiegelow, Liv Andrés-Jensen, Camilla Grud Nielsen, Ólafur Birgir Davídsson, Louise Lundgren
| Nature Verified
Abstract With increasing survival in acute lymphoblastic leukemia (ALL), long-term toxicities have become a critical aspect. A novel measure, designated Severe Toxicity-free survival (STFS), was developed through international consensus to integrate the most severe, symptomatic organ toxicities in outcome evaluation. This measure has not been applied to real-world data before.
Open in Who Shared Issue with article?

Sequelae and post‐thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol

|
By Merete Dam, Line Stensig Lynggaard, Ólafur G. Jónsson, Sonata Saulyte Trakymiene
| Wiley Online Library Verified
ALL acute lymphoblastic leukemia CVL central venous line DVT deep venous thrombosis mVS Modified Villalta Scale NOPHO Nordic Society of Pediatric Hematology and Oncology PE pulmonary embolism PTS post-thrombotic syndrome QoL quality of life VS Villalta Scale VTE venous thromboembolism 1 INTRODUCTION Acute lymphoblastic leukemia (ALL) is the most common cancer in children.
Open in Who Shared Issue with article?

Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia - Leukemia

|
By Maddalena Centanni, Line Stensig Lynggaard, Kjeld Schmiegelow, Merete Dam, Daniel Centanni, Mats Heyman
| Nature Verified
Abstract Asparaginase is an essential component of acute lymphoblastic leukemia (ALL) therapy, yet its associated toxicities often lead to treatment discontinuation, increasing the risk of relapse. Hypersensitivity reactions include clinical allergies, silent inactivation, or allergy-like responses. We hypothesized that even moderate increases in asparaginase clearance are related to later inactivation.
Open in Who Shared Issue with article?
See all 4 articles